Optical flow techniques are becoming increasingly performant and robust when estimating motion in a scene, but their performance has yet to be proven in the area of facial expression recognition. In this work, a variety of optical flow approaches are evaluated across multiple facial expression datasets, so as to provide a consistent performance evaluation. Additionally, the strengths of multiple optical flow approaches are combined in a novel data augmentation scheme. Under this scheme, increases in average accuracy of up to 6% (depending on the choice of optical flow approaches and dataset) have been achieved.

No abstract

Object detection from RGB images is a long-standing problem in image processing and computer vision. It has applications in various domains including robotics, surveillance, human-computer interaction, and medical diagnosis. With the availability of low cost 3D scanners, a large number of RGB-D object detection approaches have been proposed in the past years. This chapter provides a comprehensive survey of the recent developments in this field. We structure the chapter into two parts; the focus of the first part is on techniques that are based on hand-crafted features combined with machine learning algorithms. The focus of the second part is on the more recent work, which is based on deep learning. Deep learning techniques, coupled with the availability of large training datasets, have now revolutionized the field of computer vision, including RGB-D object detection, achieving an unprecedented level of performance. We survey the key contributions, summarize the most commonly used pipelines, discuss their benefits and limitations, and highlight some important directions for future research.

Our aim was to investigate the usefulness of machine learning approaches on linked administrative health data at the population level in predicting older patients’ one-year risk of acute coronary syndrome and death following the use of non-steroidal anti-inflammatory drugs (NSAIDs). Patients from a Western Australian cardiovascular population who were supplied with NSAIDs between 1 Jan 2003 and 31 Dec 2004 were identified from Pharmaceutical Benefits Scheme data. Comorbidities from linked hospital admissions data and medication history were inputs. Admissions for acute coronary syndrome or death within one year from the first supply date were outputs. Machine learning classification methods were used to build models to predict ACS and death. Model performance was measured by the area under the receiver operating characteristic curve (AUC-ROC), sensitivity and specificity. There were 68,889 patients in the NSAIDs cohort with mean age 76 years and 54% were female. 1882 patients were admitted for acute coronary syndrome and 5405 patients died within one year after their first supply of NSAIDs. The multi-layer neural network, gradient boosting machine and support vector machine were applied to build various classification models. The gradient boosting machine achieved the best performance with an average AUC-ROC of 0.72 predicting ACS and 0.84 predicting death. Machine learning models applied to linked administrative data can potentially improve adverse outcome risk prediction. Further investigation of additional data and approaches are required to improve the performance for adverse outcome risk prediction.

No abstract

No abstract

No abstract

To investigate the usefulness of machine learning approaches on linked administrative health data at the population level in predicting older patients’ one-year risk of adverse events after supplied with non-steroidal anti-inflammatory drugs (NSAIDs). Patients from a Western Australian cardiovascular population who were supplied with NSAIDs between 1 Jan 2003 and 31 Dec 2004 were identified from Pharmaceutical Benefits Scheme data. Comorbidities from linked hospital admissions data and medication history were inputs. Admissions for acute coronary syndrome or deaths within one year from the last supply date were outputs. Machine learning classification methods were used to build models to predict ACS and optimise their performance, measured by the area under the receiver operating characteristic curve, sensitivity and specificity. There were 69007 patients in the NSAIDs cohort with mean age 76 years and 54.3% were female. 1882 patients were admitted for acute coronary syndrome and 5405 patients dead within one year after their last supply of NSAIDs. The multi-layer neural network, gradient boosting machine and support vector machine were applied to build various classification models. The models achieved an average AUC-ROC score of 0.72 predicting ACS and 0.84 predicting death. Machine learning models applied to linked administrative data can potentially improve adverse event risk prediction. Further investigation of additional data and approaches are required further to improve the performance for adverse event risk prediction.